Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Wolf

Showing results (301-310 of 319) with videos related to

Pageof 32
Sort By:
Cancer Research|October 1, 1987
Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the ratH G Mandel, M M Manson, D J Judah, et al.
Carcinogenesis|February 14, 2003
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancerJ H Barrett, G Smith, R Waxman, et al.
Protein Science : a Publication of the Protein Society|February 27, 1999
Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolutionQ Zhao, S Modi, G Smith, et al.
Cancer Research|April 23, 1999
Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agentsA P Garner, M J Paine, I Rodriguez-Crespo, et al.
British Journal of Cancer|June 30, 2011
Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumoursS Weidlich, K Walsh, D Crowther, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2019
An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical TrialsC J Henderson, Y Kapelyukh, N Scheer, et al.
Carcinogenesis|June 1, 1992
Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibilityC R Wolf, C A Smith, A C Gough, et al.
International Journal of Cancer|June 15, 1987
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patientC R Wolf, I P Hayward, S S Lawrie, et al.
Archives of Biochemistry and Biophysics|July 1, 1996
Active-site topologies of human CYP2D6 and its aspartate-301 --> glutamate, asparagine, and glycine mutantsR Mackman, R A Tschirret-Guth, G Smith, et al.
Pharmacogenetics|March 25, 1998
The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomasC Matthias, U Bockmühl, V Jahnke, et al.
Pageof 32

Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Cancer Research|October 1, 1987
Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the ratH G Mandel, M M Manson, D J Judah, et al.
Carcinogenesis|February 14, 2003
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancerJ H Barrett, G Smith, R Waxman, et al.
Protein Science : a Publication of the Protein Society|February 27, 1999
Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolutionQ Zhao, S Modi, G Smith, et al.
Cancer Research|April 23, 1999
Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agentsA P Garner, M J Paine, I Rodriguez-Crespo, et al.
British Journal of Cancer|June 30, 2011
Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumoursS Weidlich, K Walsh, D Crowther, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 27, 2019
An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical TrialsC J Henderson, Y Kapelyukh, N Scheer, et al.
Carcinogenesis|June 1, 1992
Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibilityC R Wolf, C A Smith, A C Gough, et al.
International Journal of Cancer|June 15, 1987
Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patientC R Wolf, I P Hayward, S S Lawrie, et al.
Archives of Biochemistry and Biophysics|July 1, 1996
Active-site topologies of human CYP2D6 and its aspartate-301 --> glutamate, asparagine, and glycine mutantsR Mackman, R A Tschirret-Guth, G Smith, et al.
Pharmacogenetics|March 25, 1998
The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomasC Matthias, U Bockmühl, V Jahnke, et al.
Pageof 32